Research
-
Estimation of the Share of Net Expenditures on Insulin Captured by US Manufacturers, Wholesalers, Pharmacy Benefit Managers, Pharmacies, and Health Plans From 2014 to 2018
Recent US media and policy attention on insulin affordability has focused on the role of manufacturers in setting prices; however, the role of other drug distribution intermediaries in determining prices has received less attention.
Categorized in -
Untangling the Price of Insulin
Despite its discovery nearly 100 years ago, insulin’s list price has been going up, not down. Schaeffer Center researchers analyzes the flow of money across all distribution system participants—manufacturers, wholesalers, pharmacies, pharmacy benefit managers (PBMs), and health plans.
-
Disparities In County COVID-19 Vaccination Rates Linked To Disadvantage And Hesitancy
Despite widespread access, there are still wide discrepancies in COVID-19 vaccine coverage in communities across the U.S. Researchers with the USC Schaeffer Center for Health Policy & Economics and Johns Hopkins University assessed the relationship between county COVID-19 vaccination rates and both social vulnerability and vaccine hesitancy.
Categorized in -
County-Level COVID-19 Vaccination Coverage, By Social Vulnerability and Vaccine Hesitancy
In the charts below, we explore the impact of social vulnerability and vaccine hesitancy using data made available by the Centers for Disease Control and Prevention (CDC) and the Department of Health and Human Services. Last updated: June 5, 2022 We define hesitancy as the percentage of residents who said that they would “probably not” […]
Categorized in -
Targeting Affordability in Healthcare: A Review of the Evidence
Health plans have many tools to reduce spending and therefore reduce plan premiums, which can improve the affordability of health insurance.
Categorized in -
Financial Incentives and Other Nudges Do Not Increase COVID-19 Vaccinations among the Vaccine Hesitant
Can financial incentives, public health messages and other behavioral nudges –approaches deployed by state and local governments, employers, and health systems – increase SARS-CoV-2 vaccination rates among the vaccine hesitant in the US?
Categorized in -
Trends in Cannabis Involvement and Risk of Alcohol Involvement in Motor Vehicle Crash Fatalities in the United States, 2000‒2018
This study assesses To assess cannabis and alcohol involvement among motor vehicle crash (MVC) fatalities in the United States.
Categorized in -
Do Early-Life Social, Behavioral, and Health Exposures Increase Later-Life Arthritis Incidence?
New Schaeffer Center research shows that experiencing two or more childhood socioeconomic disadvantages is indirectly associated with osteoarthritis and rheumatoid arthritis.
Categorized in -
The 340B Drug Pricing Program: Background, Ongoing Challenges and Recent Developments
The 340B Drug Pricing Program allows eligible healthcare clinics and hospitals (“covered entities”) to purchase outpatient drugs at a 20-50% discount.
Categorized in -
Patient and Physician Perspectives On Engaging in Palliative and Healthcare Trials: A Qualitative Descriptive Study
Researchers are encountering increasing challenges in recruiting participants for palliative and healthcare research. This paper aims to understand challenges to and methods for engaging physicians and seriously ill patients and their caregivers in research studies.
Categorized in